Innovative bone-biology company operating at the confluence of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.
CORPORATE DEVELOPMENT
Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants.